×

OVERALL 94 PCT WITH ADVANCED MULTIPLE MYELOMA RESPOND TO BLUEBIRD'S BB2121 IN SMALL PHASE I STUDY -DATA

OVERALL 94 PCT WITH ADVANCED MULTIPLE MYELOMA RESPOND TO BLUEBIRD'S BB2121 IN SMALL PHASE I STUDY -DATA